182 related articles for article (PubMed ID: 30256630)
1. A Platform To Enhance Quantitative Single Molecule Localization Microscopy.
Golfetto O; Wakefield DL; Cacao EE; Avery KN; Kenyon V; Jorand R; Tobin SJ; Biswas S; Gutierrez J; Clinton R; Ma Y; Horne DA; Williams JC; Jovanović-Talisman T
J Am Chem Soc; 2018 Oct; 140(40):12785-12797. PubMed ID: 30256630
[TBL] [Abstract][Full Text] [Related]
2. Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2.
Tobin SJ; Wakefield DL; Jones V; Liu X; Schmolze D; Jovanović-Talisman T
Sci Rep; 2018 Oct; 8(1):15154. PubMed ID: 30310083
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of HER2 in Patient Tissues with Touch Prep-Quantitative Single Molecule Localization Microscopy.
Wakefield DL; Tobin SJ; Schmolze D; Jovanovic-Talisman T
Methods Mol Biol; 2022; 2394():231-248. PubMed ID: 35094332
[TBL] [Abstract][Full Text] [Related]
4. Optical fiber-based in vivo quantification of growth factor receptors.
Thomas TP; Chang YC; Ye JY; Kotlyar A; Cao Z; Shukla R; Qin S; Norris TB; Baker JR
Cancer; 2012 Apr; 118(8):2148-56. PubMed ID: 22488668
[TBL] [Abstract][Full Text] [Related]
5. An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
Schwarz LJ; Hutchinson KE; Rexer BN; Estrada MV; Gonzalez Ericsson PI; Sanders ME; Dugger TC; Formisano L; Guerrero-Zotano A; Red-Brewer M; Young CD; Lantto J; Pedersen MW; Kragh M; Horak ID; Arteaga CL
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059433
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Single-Molecule Localization Microscopy (qSMLM) of Membrane Proteins Based on Kinetic Analysis of Fluorophore Blinking Cycles.
Fricke F; Beaudouin J; Malkusch S; Eils R; Heilemann M
Methods Mol Biol; 2017; 1663():115-126. PubMed ID: 28924663
[TBL] [Abstract][Full Text] [Related]
7. Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.
Razumienko EJ; Scollard DA; Reilly RM
J Nucl Med; 2012 Dec; 53(12):1943-50. PubMed ID: 23096164
[TBL] [Abstract][Full Text] [Related]
8. High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers.
Van Acker T; Buckle T; Van Malderen SJM; van Willigen DM; van Unen V; van Leeuwen FWB; Vanhaecke F
Anal Chim Acta; 2019 Oct; 1074():43-53. PubMed ID: 31159938
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.
El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR
Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742
[No Abstract] [Full Text] [Related]
10. Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.
Ekberg T; Nestor M; Engström M; Nordgren H; Wester K; Carlsson J; Anniko M
Int J Oncol; 2005 May; 26(5):1177-85. PubMed ID: 15809707
[TBL] [Abstract][Full Text] [Related]
11. Automated Stoichiometry Analysis of Single-Molecule Fluorescence Imaging Traces via Deep Learning.
Xu J; Qin G; Luo F; Wang L; Zhao R; Li N; Yuan J; Fang X
J Am Chem Soc; 2019 May; 141(17):6976-6985. PubMed ID: 30950273
[TBL] [Abstract][Full Text] [Related]
12. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR.
Labuhn M; Vuaroqueaux V; Fina F; Schaller A; Nanni-Metellus I; Kung W; Eppenberger-Castori S; Martin PM; Eppenberger U
Int J Biol Markers; 2006; 21(1):30-9. PubMed ID: 16711511
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects.
Polosa R; Puddicombe SM; Krishna MT; Tuck AB; Howarth PH; Holgate ST; Davies DE
J Allergy Clin Immunol; 2002 Jan; 109(1):75-81. PubMed ID: 11799369
[TBL] [Abstract][Full Text] [Related]
15. Site-selective in situ growth of fluorescent polymer-antibody conjugates with enhanced antigen detection by signal amplification.
Zhang L; Zhao W; Liu X; Wang G; Wang Y; Li D; Xie L; Gao Y; Deng H; Gao W
Biomaterials; 2015 Sep; 64():2-9. PubMed ID: 26102329
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of Her2-NLP peptide conjugates targeting circulating breast cancer cells: cellular uptake and localization by fluorescent microscopic imaging.
Cai H; Singh AN; Sun X; Peng F
J Fluoresc; 2015 Jan; 25(1):113-7. PubMed ID: 25620472
[TBL] [Abstract][Full Text] [Related]
17. A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.
Lee-Hoeflich ST; Crocker L; Yao E; Pham T; Munroe X; Hoeflich KP; Sliwkowski MX; Stern HM
Cancer Res; 2008 Jul; 68(14):5878-87. PubMed ID: 18632642
[TBL] [Abstract][Full Text] [Related]
18. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.
Barrett T; Koyama Y; Hama Y; Ravizzini G; Shin IS; Jang BS; Paik CH; Urano Y; Choyke PL; Kobayashi H
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6639-48. PubMed ID: 17982120
[TBL] [Abstract][Full Text] [Related]
19. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
Razumienko E; Dryden L; Scollard D; Reilly RM
Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
[TBL] [Abstract][Full Text] [Related]
20. Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas.
Leto SM; Sassi F; Catalano I; Torri V; Migliardi G; Zanella ER; Throsby M; Bertotti A; Trusolino L
Clin Cancer Res; 2015 Dec; 21(24):5519-31. PubMed ID: 26296355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
